Business Description
BetterLife Pharma Inc
NAICS : 325410
SIC : 3741
ISIN : CA72580T2020
Total Employee Number:
4Description
BetterLife Pharma Inc is an emerging biotechnology company focused on developing and commercializing the compound BETR-001 to treat neuropsychiatric and neurological disorders. BETR-001 is a non-hallucinogenic and non-controlled LSD derivative in development, and it is unregulated and therefore can be self-administered. BetterLife's synthesis patent for BETR-001 eliminates regulatory hurdles, and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder, and other neuropsychiatric and neurological disorders.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -40.2 | |||||
Debt-to-Equity | -0.11 | |||||
Debt-to-EBITDA | -0.6 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 56.2 | |||||
3-Year EPS without NRI Growth Rate | 47.7 | |||||
3-Year FCF Growth Rate | 38.3 | |||||
3-Year Book Growth Rate | 18.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.71 | |||||
9-Day RSI | 49.48 | |||||
14-Day RSI | 50.8 | |||||
3-1 Month Momentum % | 454.84 | |||||
6-1 Month Momentum % | 454.84 | |||||
12-1 Month Momentum % | 273.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19 | |||||
Shareholder Yield % | 0.2 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -779.65 | |||||
ROIC % | -150.88 | |||||
3-Year ROIIC % | 1315.9 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -31.91 | |||||
EV-to-EBITDA | -31.91 | |||||
EV-to-FCF | -65.1 | |||||
Earnings Yield (Greenblatt) % | -3.13 | |||||
FCF Yield % | -1.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BetterLife Pharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.008 | ||
| Beta | 1.4286 | ||
| 3-Year Sharpe Ratio | 0.72 | ||
| 3-Year Sortino Ratio | 2.27 | ||
| Volatility % | 190.15 | ||
| 14-Day RSI | 50.8 | ||
| 14-Day ATR (€) | 0.021217 | ||
| 20-Day SMA (€) | 0.18555 | ||
| 12-1 Month Momentum % | 273.91 | ||
| 52-Week Range (€) | 0.0175 - 0.266 | ||
| Shares Outstanding (Mil) | 170.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BetterLife Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BetterLife Pharma Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2020-06-26 | 1.00 (-5.24%) |
Show
Entries
BetterLife Pharma Inc Frequently Asked Questions
What is BetterLife Pharma Inc(FRA:NPAU)'s stock price today?
The current price of FRA:NPAU is €0.18. The 52 week high of FRA:NPAU is €0.27 and 52 week low is €0.02.
When is next earnings date of BetterLife Pharma Inc(FRA:NPAU)?
The next earnings date of BetterLife Pharma Inc(FRA:NPAU) is .
Does BetterLife Pharma Inc(FRA:NPAU) pay dividends? If so, how much?
BetterLife Pharma Inc(FRA:NPAU) does not pay dividend.
Press Release
Articles on BetterLife Pharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers